View Clinical Trial (Medical Research Study)
Metastatic Colorectal Cancer - PEAK Study - East Setauket NY (Clinical Trial 6197) (Clinical Trial 6197)
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.
|
 |
 |
| City: |
|
East Setauket |
| State: |
|
NY |
| Zip Code: |
|
11733 |
| Study summary: |
|
Individuals with colorectal cancer that has metastasized (spread) are invited to inquire about participation in a clinical research study. This study will evaluate an investigational fully human monoclonal antibody combined with chemotherapy to see if it will extend survival for a longer period of time, compared to the best available standard of care regimen. Monoclonal antibodies are substances produced in a laboratory that can locate and bind to cancer cells by recognizing specific substances on cancer cells. These antibodies are used to find and attack tumors.
|
| Qualified participants must: |
|
• Have unresectable (inoperable) colorectal cancer that has metastasized (spread)
•
Be at least 18 years of age
•
Not have received a prior treatment regimen for their advanced-stage colorectal cancer
•
Meet other enrollment criteria |
| Participants will receive: |
|
Study-related medication and study-related procedures at no cost |
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or effectiveness of new drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at and participating in a study at About Clinical Trials or take the Participation Quiz to find out if you are a good candidate for clinical trial participation.